NIOX Group PLC (NIOX)
Industry Medical Devices
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
61.00p
Buy
61.80p
0.20p (+0.33%)
Prices updated at 15 May 2026, 16:38 BST
| Prices minimum 15 mins delay
Prices in GBX
Circassia Pharmaceuticals PLC is a biotechnology company. It is engaged in the development and commercialization of range of therapies for asthma and chronic obstructive pulmonary disease.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 42m | 49m | |
| 30m | 34m | |
| 8m | 11m | |
| 18.42 | 21.97 | |
| 4m | 7m | |
| 12m | 15m | |
| Sales, General and administrative | 20m | 20m |
| Interest expenses | 100,000 | - |
| Provision for income taxes | 4m | 4m |
| Operating expenses | 23m | 23m |
| Income before taxes | 8m | 11m |
| Net income available to common shareholders | 4m | 7m |
| 0.0088 | 0.0169 | |
| Net interest income | 700,000 | 200,000 |
| Advertising and promotion | - | - |
| Net investment income, net | -500,000 | -300,000 |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 0.0083 | 0.0164 |
| Free cash flow per share | 0.0266 | 0.0385 |
| Book value/share | 0.2055 | 0.1541 |
| Debt equity ratio | 0.013445 | 0.007396 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 21m | 31m |
| Current liabilities | 8m | 8m |
| Total capital | 60m | 68m |
| Total debt | 2m | 1m |
| Total equity | 60m | 68m |
| Total non current liabilities | - | - |
| Loans | - | - |
| Total assets | 68m | 76m |
| Total liabilities | - | - |
| Cash and cash equivalents | 11m | 20m |
| Common stock | 398m | 418m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 20m | 11m |
| Cash dividends paid | -4m | -5m |
| 16m | 14m | |
| Investments (gains) losses | -1m | -1m |
| 11m | 20m | |
| Net income | - | - |
| 17m | 15m | |
| -1m | -1m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.